EUVIMEDEUVIMED entdecken
Crossref

Human Campylobacter spp. infections in Italy

Verena Zerbato, Stefano Di Bella, Riccardo Pol, Roberto Luzzati, Gianfranco Sanson, Simone Ambretti, Stefano Andreoni, Richard Aschbacher, Mariano Bernardo, Alessandra Bielli, Gioconda Brigante, Marina Busetti und 37 weitere

European Journal of Clinical Microbiology & Infectious Diseases · 2024

DOI: 10.1007/s10096-024-04803-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Verena Zerbato und 48 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Trieste University Hospital (ASUGI), Trieste, Italy. verena.zerbato@gmail.com. Hauptthemen laut MEDLINE: Campylobacter Infections, Anti-Bacterial Agents, Microbial Sensitivity Tests, Campylobacter. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Campylobacter is a frequent cause of enteric infections with common antimicrobial resistance issues. The most recent reports of campylobacteriosis in Italy include data from 2013 to 2016. We aimed to provide national epidemiological and microbiological data on human Campylobacter infections in Italy during the period 2017-2021. METHODS: Data was collected from 19 Hospitals in 13 Italian Regions. Bacterial identification was performed by mass spectrometry. Antibiograms were determined with Etest or Kirby-Bauer (EUCAST criteria). RESULTS: In total, 5419 isolations of Campylobacter spp. were performed. The most common species were C. jejuni (n = 4535, 83.7%), followed by C. coli (n = 732, 13.5%) and C. fetus (n = 34, 0.6%). The mean age of patients was 34.61 years and 57.1% were males. Outpatients accounted for 54% of the cases detected. Campylobacter were isolated from faeces in 97.3% of cases and in 2.7% from blood. C. fetus was mostly isolated from blood (88.2% of cases). We tested for antimicrobial susceptibility 4627 isolates (85.4%). Resistance to ciprofloxacin and tetracyclines was 75.5% and 54.8%, respectively; resistance to erythromycin was 4.8%; clarithromycin 2% and azithromycin 2%. 50% of C. jejuni and C. coli were resistant to ≥ 2 antibiotics. Over the study period, resistance to ciprofloxacin and tetracyclines significantly decreased (p < 0.005), while resistance to macrolides remained stable. CONCLUSION: Campylobacter resistance to fluoroquinolones and tetracyclines in Italy is decreasing but is still high, while macrolides retain good activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Campylobacter InfectionsAnti-Bacterial AgentsMicrobial Sensitivity TestsCampylobacterHumansItalyFemaleMaleAdultMiddle AgedYoung AdultAdolescentAgedChildChild, PreschoolInfantFecesDrug Resistance, BacterialAged, 80 and overInfant, NewbornCampylobacter jejuni

Stichwörter der Autor:innen

Campylobacter jejuni(6): Campylobacter sppAntimicrobial resistanceItalyMultidrug-resistantSurveillance

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Infectious Diseases Unit, Trieste University Hospital (ASUGI), Trieste, Italy. verena.zerbato@gmail.com.
  • Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste, Italy.
  • Infectious Diseases Unit, Trieste University Hospital (ASUGI), Trieste, Italy.
  • Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
  • Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
  • Laboratory of Microbiology and Virology, Azienda Ospedaliero Universitaria Maggiore Della Carità, Corso Mazzini 18, Novara, Italy.

Zitieren

APA

Zerbato, V., Di Bella, S., Pol, R., Luzzati, R., Sanson, G., Ambretti, S., Andreoni, S., Aschbacher, R., Bernardo, M., Bielli, A., Brigante, G., Busetti, M., Camarlinghi, G., Carcione, D., Carducci, A., Clementi, N., Carretto, E., Chilleri, C., Codda, G., …, & Principe, L. (2024). Human Campylobacter spp. infections in Italy. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04803-0

Vancouver

Zerbato V, Di Bella S, Pol R, Luzzati R, Sanson G, Ambretti S, et al. Human Campylobacter spp. infections in Italy. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04803-0

BibTeX
@article{Zerbato2024,
  author = {Zerbato, Verena and Di Bella, Stefano and Pol, Riccardo and Luzzati, Roberto and Sanson, Gianfranco and Ambretti, Simone and Andreoni, Stefano and Aschbacher, Richard and Bernardo, Mariano and Bielli, Alessandra and Brigante, Gioconda and Busetti, Marina and Camarlinghi, Giulio and Carcione, Davide and Carducci, Antonella and Clementi, Nicola and Carretto, Edoardo and Chilleri, Chiara and Codda, Giulia and Consonni, Alessandra and Costantino, Venera and Cortazzo, Venere and Di Santolo, Manuela and Dodaro, Saveria and Fiori, Barbara and García-Fernández, Aurora and Foschi, Claudio and Gobbato, Elisa and Greco, Francesca and La Ragione, Roberto Marcello and Mancini, Nicasio and Maraolo, Alberto Enrico and Marchese, Anna and Marcuccio, Daniela and Marrollo, Roberta and Mauri, Carola and Mazzariol, Annarita and Morroni, Gianluca and Mosca, Adriana and Nigrisoli, Giacomo and Pagani, Elisabetta and Parisio, Eva Maria and Pollini, Simona and Sarti, Mario and Sorrentino, Annarita and Trotta, Domenico and Villa, Laura and Vismara, Chiara and Principe, Luigi},
  title = {Human Campylobacter spp. infections in Italy},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  doi = {10.1007/s10096-024-04803-0}
}
Kostenlos starten →